Literature DB >> 28043896

Marrow adipose tissue composition in adults with morbid obesity.

Elaine W Yu1, Logan Greenblatt1, Alireza Eajazi2, Martin Torriani2, Miriam A Bredella3.   

Abstract

Patients with type 2 diabetes mellitus (T2DM) have increased fracture risk despite normal or increased bone mineral density (BMD). Elevations in marrow adipose tissue (MAT) and declines in MAT unsaturation are both associated with increased skeletal fragility. The objective of our study was to characterize the quantity and composition of MAT in adults with morbid obesity and T2DM, and to evaluate determinants of MAT. We studied 21 adults with morbid obesity prior to bariatric surgery, 8 of whom had T2DM. All subjects underwent 1H-MR spectroscopy of the lumbar spine and femur for assessment of MAT and dual-energy x-ray absorptiometry (DXA) and quantitative computed tomography (QCT) of the lumbar spine and hip for assessment of areal BMD (aBMD) and volumetric BMD (vBMD). Visceral (VAT) and subcutaneous adipose tissue (SAT) were quantified by CT at L1-L2. Subjects with T2DM had higher vBMD of the femoral neck and higher total MAT at the lumbar spine and femoral metaphysis compared to non-diabetic controls (p≤0.04). Lipid unsaturation index (UI) was significantly lower at the femoral diaphysis in T2DM (p=0.03). Within the entire cohort, HbA1c was positively associated with MAT (p≤0.03), and age was associated with higher MAT and lower MAT unsaturation (p≤0.05). Lumbar spine vBMD was inversely associated with lumbar spine MAT (p=0.04). There was an inverse association between SAT and diaphyseal MAT (p<0.05) while there were no associations with VAT. Subjects with morbid obesity and T2DM have higher MAT with a lower proportion of unsaturated lipids, despite higher femoral neck vBMD. MAT is positively associated with age and HbA1c, and inversely associated with vBMD, suggesting that MAT may serve as an imaging biomarker of skeletal health and metabolic risk.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dual-energy x-ray absorptiometry (DXA); Marrow adipose tissue (MAT); Marrow adipose tissue composition; Morbid obesity; Proton MR spectroscopy, bone mineral density; Quantitative computed tomography (QCT); Type 2 diabetes mellitus (T2DM)

Mesh:

Substances:

Year:  2016        PMID: 28043896      PMCID: PMC5367964          DOI: 10.1016/j.bone.2016.12.018

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  40 in total

1.  Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice.

Authors:  Mark W Hamrick; Mary Anne Della-Fera; Yang-Ho Choi; Catherine Pennington; Diane Hartzell; Clifton A Baile
Journal:  J Bone Miner Res       Date:  2005-01-18       Impact factor: 6.741

2.  A High Fat Diet Increases Bone Marrow Adipose Tissue (MAT) But Does Not Alter Trabecular or Cortical Bone Mass in C57BL/6J Mice.

Authors:  Casey R Doucette; Mark C Horowitz; Ryan Berry; Ormond A MacDougald; Rea Anunciado-Koza; Robert A Koza; Clifford J Rosen
Journal:  J Cell Physiol       Date:  2015-09       Impact factor: 6.384

Review 3.  Marrow fat metabolism is linked to the systemic energy metabolism.

Authors:  Beata Lecka-Czernik
Journal:  Bone       Date:  2011-07-04       Impact factor: 4.398

4.  FRAX underestimates fracture risk in patients with diabetes.

Authors:  Lora M Giangregorio; William D Leslie; Lisa M Lix; Helena Johansson; Anders Oden; Eugene McCloskey; John A Kanis
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

5.  Potential value of vertebral proton MR spectroscopy in determining bone weakness.

Authors:  D Schellinger; C S Lin; H G Hatipoglu; D Fertikh
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

6.  High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity.

Authors:  B Lecka-Czernik; L A Stechschulte; P J Czernik; A R Dowling
Journal:  Mol Cell Endocrinol       Date:  2015-01-07       Impact factor: 4.102

7.  Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures.

Authors:  Janina M Patsch; Xiaojuan Li; Thomas Baum; Samuel P Yap; Dimitrios C Karampinos; Ann V Schwartz; Thomas M Link
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

8.  Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1.

Authors:  S Huang; M Kaw; M T Harris; N Ebraheim; M F McInerney; S M Najjar; B Lecka-Czernik
Journal:  Bone       Date:  2010-01-04       Impact factor: 4.398

9.  Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes.

Authors:  Li-Fen Liu; Wen-Jun Shen; Masami Ueno; Shailja Patel; Fredric B Kraemer
Journal:  BMC Genomics       Date:  2011-05-05       Impact factor: 3.969

10.  Type 2 diabetes and risk of low-energy fractures in postmenopausal women: meta-analysis of observational studies.

Authors:  Joanna Dytfeld; Michał Michalak
Journal:  Aging Clin Exp Res       Date:  2016-04-12       Impact factor: 3.636

View more
  34 in total

Review 1.  Bone Marrow Adiposity: Basic and Clinical Implications.

Authors:  Zachary L Sebo; Elizabeth Rendina-Ruedy; Gene P Ables; Dieter M Lindskog; Matthew S Rodeheffer; Pouneh K Fazeli; Mark C Horowitz
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

Review 2.  The Regulation of Marrow Fat by Vitamin D: Molecular Mechanisms and Clinical Implications.

Authors:  Hanel Sadie-Van Gijsen
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

3.  1H-MRS of femoral red and yellow bone marrow fat composition and water content in healthy young men and women at 3 T.

Authors:  Jesper Lundbom; Alessandra Bierwagen; Kalman Bodis; Maria Apostolopoulou; Julia Szendroedi; Karsten Müssig; Jong-Hee Hwang; Michael Roden
Journal:  MAGMA       Date:  2019-05-02       Impact factor: 2.310

4.  Imaging of diabetic bone.

Authors:  Federico Ponti; Sara Guerri; Claudia Sassi; Giuseppe Battista; Giuseppe Guglielmi; Alberto Bazzocchi
Journal:  Endocrine       Date:  2017-03-14       Impact factor: 3.633

Review 5.  Bone Marrow Adipocyte Developmental Origin and Biology.

Authors:  Joanna Bukowska; Trivia Frazier; Stanley Smith; Theodore Brown; Robert Bender; Michelle McCarthy; Xiying Wu; Bruce A Bunnell; Jeffrey M Gimble
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

Review 6.  Energy Metabolism of Bone.

Authors:  Katherine J Motyl; Anyonya R Guntur; Adriana Lelis Carvalho; Clifford J Rosen
Journal:  Toxicol Pathol       Date:  2017-11-02       Impact factor: 1.902

7.  Bone Marrow Fat Changes After Gastric Bypass Surgery Are Associated With Loss of Bone Mass.

Authors:  Tiffany Y Kim; Ann V Schwartz; Xiaojuan Li; Kaipin Xu; Dennis M Black; Dimitry M Petrenko; Lygia Stewart; Stanley J Rogers; Andrew M Posselt; Jonathan T Carter; Dolores M Shoback; Anne L Schafer
Journal:  J Bone Miner Res       Date:  2017-08-09       Impact factor: 6.741

8.  Bone marrow adipose tissue composition following high-caloric feeding and fasting.

Authors:  Miriam A Bredella; Colleen Buckless; Pouneh K Fazeli; Clifford J Rosen; Martin Torriani; Anne Klibanski; Karen K Miller
Journal:  Bone       Date:  2021-06-27       Impact factor: 4.398

Review 9.  Marrow adipose tissue imaging in humans.

Authors:  Vibha Singhal; Miriam A Bredella
Journal:  Bone       Date:  2018-01-10       Impact factor: 4.398

10.  Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male Mice.

Authors:  Sheila Bornstein; Michele Moschetta; Yawara Kawano; Antonio Sacco; Daisy Huynh; Daniel Brooks; Salomon Manier; Heather Fairfield; Carolyne Falank; Aldo M Roccaro; Kenichi Nagano; Roland Baron; Mary Bouxein; Calvin Vary; Irene M Ghobrial; Clifford J Rosen; Michaela R Reagan
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.